Chronic Fatigue Syndrome

Myalgic Encephalomyelitis (ME), also known as Chronic Fatigue Syndrome (CFS), has been a long-term conundrum for medical practitioners. With no evidence-based laboratory tests for diagnosis validated or treatments, ME/CFS has been inaccurately attributed to psychological causes and lack of stamina which has led to stigmatisation. Patients rarely found specialists who would see them for the condition and often turned to alternative health care providers for answers. Over the last decade mainstream medicine has gained a greater understanding of ME/CFS.
Capital Health Network together with two of Australia's pre-eminent ME/CFS researchers, Professor Sonya Marshall-Gradisnik and Dr Natalie Eaton-Fitch from the Griffith University, National Centre for Neuroimmunology and Emerging Diseases (NCNED) invite you to a webinar to update primary health care providers about the latest ME/CFS research and evidence for ME/CFS management.

Learning Outcomes:
Identify the appropriate screening tests for patients presenting with ME/CFS
Outline the symptoms and diagnostic features of ME/CFS
Explain the role of allied health providers in the care of patients with ME/CFS
Summarise the evidence for medications such as Low Dose Naltrexone
Discuss emerging research in the field of ME/CFS
Outline resources available to patients and primary care providers such as online education, support groups and clinics.


Disclaimer: "Please Note: The educational content presented in this video is based on information available up to [5th October 2023]. As knowledge and understanding evolve over time, some of the information provided may become outdated or irrelevant in the future. Viewers are advised to verify and cross-reference any critical information with up-to-date sources. The intention of this video is to offer insights and knowledge as of its creation date and should not be relied upon as a substitute for current and accurate information. Always stay informed and seek professional advice where necessary.